|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with HER2 x CD47 x CD3ε
100 Translational Medicine associated with HER2 x CD47 x CD3ε
0 Patents (Medical) associated with HER2 x CD47 x CD3ε